Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berend Malchow

Showing results (1-10 of 115) with videos related to

Pageof 12
Sort By:
Psychiatrische Praxis|March 6, 2013
[Generation y: problematic consequences for psychiatry and psychotherapy - pro & contra]Berend Malchow
Psychiatria Danubina|April 15, 2023
Monoclonal Antibody Therapy in Autoantibody-Associated Psychotic Disorders and Schizophrenia: Narrative Review of Past and Current Clinical TrialsNiels Hansen, Berend Malchow
Behavioural Brain Research|October 28, 2025
Autoantibodies and psychiatric diseasesNiels Hansen, Berend Malchow
Journal of Neural Transmission (Vienna, Austria : 1996)|July 14, 2023
Drug repurposing and new drug targets: perspectives for novel treatment options in mental health disordersBerend Malchow, Jens Wiltfang
Current Opinion in Psychiatry|February 24, 2017
Aerobic exercise and its effects on cognition in schizophreniaPeter Falkai, Berend Malchow, Andrea Schmitt
MMW Fortschritte Der Medizin|June 17, 2014
[Physical activity in mental disorders]Berend Malchow, Andrea Schmitt, Peter Falkai
Schizophrenia Research|July 11, 2020
Imaging the effects of exercise on the brainJoseph Firth, Berend Malchow, Joseph Ventura
MMW Fortschritte Der Medizin|October 21, 2010
[The speechless patient]Berend Malchow, Peter Falkai, Thomas Wobrock
Neural Plasticity|April 14, 2015
Efficacy and interindividual variability in motor-cortex plasticity following anodal tDCS and paired-associative stimulationWolfgang Strube, Tilmann Bunse, Berend Malchow, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 5, 2013
Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disordersKenji Hashimoto, Berend Malchow, Peter Falkai, et al.
Pageof 12

Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
Psychiatrische Praxis|March 6, 2013
[Generation y: problematic consequences for psychiatry and psychotherapy - pro & contra]Berend Malchow
Psychiatria Danubina|April 15, 2023
Monoclonal Antibody Therapy in Autoantibody-Associated Psychotic Disorders and Schizophrenia: Narrative Review of Past and Current Clinical TrialsNiels Hansen, Berend Malchow
Behavioural Brain Research|October 28, 2025
Autoantibodies and psychiatric diseasesNiels Hansen, Berend Malchow
Journal of Neural Transmission (Vienna, Austria : 1996)|July 14, 2023
Drug repurposing and new drug targets: perspectives for novel treatment options in mental health disordersBerend Malchow, Jens Wiltfang
Current Opinion in Psychiatry|February 24, 2017
Aerobic exercise and its effects on cognition in schizophreniaPeter Falkai, Berend Malchow, Andrea Schmitt
MMW Fortschritte Der Medizin|June 17, 2014
[Physical activity in mental disorders]Berend Malchow, Andrea Schmitt, Peter Falkai
Schizophrenia Research|July 11, 2020
Imaging the effects of exercise on the brainJoseph Firth, Berend Malchow, Joseph Ventura
MMW Fortschritte Der Medizin|October 21, 2010
[The speechless patient]Berend Malchow, Peter Falkai, Thomas Wobrock
Neural Plasticity|April 14, 2015
Efficacy and interindividual variability in motor-cortex plasticity following anodal tDCS and paired-associative stimulationWolfgang Strube, Tilmann Bunse, Berend Malchow, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 5, 2013
Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disordersKenji Hashimoto, Berend Malchow, Peter Falkai, et al.
Pageof 12